US FDA, Author at Express Pharma - Page 224 of 1178

FDA updates guidance to address spread of misinformation

Transforming India’s pharma sector: Opportunities and Innovations under Modi 3.0

Pharma industry experts eye budget boost for innovation and global ambitions

Industry reports 76 deals worth $5B in June 2023: GlobalData

H.E.L Group appoints Dr Yih-Shing Duh as Chief Scientific Advisor

Structure, functions and methods to remove endotoxins from biologic formulations

Preventative treatment of chronic migraine will continue to evolve in short-term with anti-CGRP mAbs effectiveness

The business development landscape of VMS in Pharma: India – Asia Perspective

Why India must legalise and regulate hemp products

MODIFI unveils growth – boosting solutions for pharma SMEs at IPC, backs ‘Make in India’ drive